These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 33785752)

  • 1. Fasting alters the gut microbiome reducing blood pressure and body weight in metabolic syndrome patients.
    Maifeld A; Bartolomaeus H; Löber U; Avery EG; Steckhan N; Markó L; Wilck N; Hamad I; Šušnjar U; Mähler A; Hohmann C; Chen CY; Cramer H; Dobos G; Lesker TR; Strowig T; Dechend R; Bzdok D; Kleinewietfeld M; Michalsen A; Müller DN; Forslund SK
    Nat Commun; 2021 Mar; 12(1):1970. PubMed ID: 33785752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent Fasting Improves Cardiometabolic Risk Factors and Alters Gut Microbiota in Metabolic Syndrome Patients.
    Guo Y; Luo S; Ye Y; Yin S; Fan J; Xia M
    J Clin Endocrinol Metab; 2021 Jan; 106(1):64-79. PubMed ID: 33017844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiome of a porcine model of metabolic syndrome and HF-pEF.
    O'Donovan AN; Herisson FM; Fouhy F; Ryan PM; Whelan D; Johnson CN; Cluzel G; Ross RP; Stanton C; Caplice NM
    Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H590-H603. PubMed ID: 32031871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Korean-Style Balanced Diet Has a Potential Connection with
    Wu X; Unno T; Kang S; Park S
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33546299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between fatty acids intake and Clostridium coccoides in obese individuals with metabolic syndrome.
    Jamar G; Santamarina AB; Dias GC; Masquio DCL; de Rosso VV; Pisani LP
    Food Res Int; 2018 Nov; 113():86-92. PubMed ID: 30195549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota and Fecal Levels of Short-Chain Fatty Acids Differ Upon 24-Hour Blood Pressure Levels in Men.
    Huart J; Leenders J; Taminiau B; Descy J; Saint-Remy A; Daube G; Krzesinski JM; Melin P; de Tullio P; Jouret F
    Hypertension; 2019 Oct; 74(4):1005-1013. PubMed ID: 31352822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay between dietary phenolic compound intake and the human gut microbiome in hypertension: A cross-sectional study.
    Calderón-Pérez L; Llauradó E; Companys J; Pla-Pagà L; Pedret A; Rubió L; Gosalbes MJ; Yuste S; Solà R; Valls RM
    Food Chem; 2021 May; 344():128567. PubMed ID: 33203597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between Diet, the Gut Microbiome, and Short-Chain Fatty Acid Production among Older Caribbean Latino Adults.
    Maldonado-Contreras A; Noel SE; Ward DV; Velez M; Mangano KM
    J Acad Nutr Diet; 2020 Dec; 120(12):2047-2060.e6. PubMed ID: 32798072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent fasting contributes to aligned circadian rhythms through interactions with the gut microbiome.
    Daas MC; de Roos NM
    Benef Microbes; 2021 Apr; 12(2):147-161. PubMed ID: 33530881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota Composition is Associated with Responses to Peanut Intervention in Multiple Parameters Among Adults with Metabolic Syndrome Risk.
    Wang S; Zhang L; Wang D; Huang M; Zhao J; Malik V; Liu X; Sun L; Lin X; Chen Y
    Mol Nutr Food Res; 2021 Sep; 65(18):e2001051. PubMed ID: 34327851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome.
    Lien LF; Brown AJ; Ard JD; Loria C; Erlinger TP; Feldstein AC; Lin PH; Champagne CM; King AC; McGuire HL; Stevens VJ; Brantley PJ; Harsha DW; McBurnie MA; Appel LJ; Svetkey LP
    Hypertension; 2007 Oct; 50(4):609-16. PubMed ID: 17698724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond gut feelings: how the gut microbiota regulates blood pressure.
    Marques FZ; Mackay CR; Kaye DM
    Nat Rev Cardiol; 2018 Jan; 15(1):20-32. PubMed ID: 28836619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology.
    Dao MC; Everard A; Aron-Wisnewsky J; Sokolovska N; Prifti E; Verger EO; Kayser BD; Levenez F; Chilloux J; Hoyles L; ; Dumas ME; Rizkalla SW; Doré J; Cani PD; Clément K
    Gut; 2016 Mar; 65(3):426-36. PubMed ID: 26100928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic phenotypes and the gut microbiota in response to dietary resistant starch type 2 in normal-weight subjects: a randomized crossover trial.
    Zhang L; Ouyang Y; Li H; Shen L; Ni Y; Fang Q; Wu G; Qian L; Xiao Y; Zhang J; Yin P; Panagiotou G; Xu G; Ye J; Jia W
    Sci Rep; 2019 Mar; 9(1):4736. PubMed ID: 30894560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole grain-rich diet reduces body weight and systemic low-grade inflammation without inducing major changes of the gut microbiome: a randomised cross-over trial.
    Roager HM; Vogt JK; Kristensen M; Hansen LBS; Ibrügger S; Mærkedahl RB; Bahl MI; Lind MV; Nielsen RL; Frøkiær H; Gøbel RJ; Landberg R; Ross AB; Brix S; Holck J; Meyer AS; Sparholt MH; Christensen AF; Carvalho V; Hartmann B; Holst JJ; Rumessen JJ; Linneberg A; Sicheritz-Pontén T; Dalgaard MD; Blennow A; Frandsen HL; Villas-Bôas S; Kristiansen K; Vestergaard H; Hansen T; Ekstrøm CT; Ritz C; Nielsen HB; Pedersen OB; Gupta R; Lauritzen L; Licht TR
    Gut; 2019 Jan; 68(1):83-93. PubMed ID: 29097438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis.
    He Y; Wu W; Wu S; Zheng HM; Li P; Sheng HF; Chen MX; Chen ZH; Ji GY; Zheng ZD; Mujagond P; Chen XJ; Rong ZH; Chen P; Lyu LY; Wang X; Xu JB; Wu CB; Yu N; Xu YJ; Yin J; Raes J; Ma WJ; Zhou HW
    Microbiome; 2018 Sep; 6(1):172. PubMed ID: 30249275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome score and ambulatory blood pressure in untreated essential hypertension.
    Cuspidi C; Meani S; Valerio C; Catini E; Fusi V; Sala C; Zanchetti A
    Blood Press Monit; 2005 Aug; 10(4):175-80. PubMed ID: 16077262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoquercetin and inulin synergistically modulate the gut microbiome to prevent development of the metabolic syndrome in mice fed a high fat diet.
    Tan S; Caparros-Martin JA; Matthews VB; Koch H; O'Gara F; Croft KD; Ward NC
    Sci Rep; 2018 Jul; 8(1):10100. PubMed ID: 29973701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metatranscriptomic analysis to define the Secrebiome, and 16S rRNA profiling of the gut microbiome in obesity and metabolic syndrome of Mexican children.
    Gallardo-Becerra L; Cornejo-Granados F; García-López R; Valdez-Lara A; Bikel S; Canizales-Quinteros S; López-Contreras BE; Mendoza-Vargas A; Nielsen H; Ochoa-Leyva A
    Microb Cell Fact; 2020 Mar; 19(1):61. PubMed ID: 32143621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut-Specific Delivery of T-Helper 17 Cells Reduces Obesity and Insulin Resistance in Mice.
    Hong CP; Park A; Yang BG; Yun CH; Kwak MJ; Lee GW; Kim JH; Jang MS; Lee EJ; Jeun EJ; You G; Kim KS; Choi Y; Park JH; Hwang D; Im SH; Kim JF; Kim YK; Seoh JY; Surh CD; Kim YM; Jang MH
    Gastroenterology; 2017 Jun; 152(8):1998-2010. PubMed ID: 28246016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.